These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7865168)

  • 21. Stimulation of adenosine A2a receptors in the rat striatum induces catalepsy that is reversed by antagonists of N-methyl-D-aspartate receptors.
    Hauber W; Münkle M
    Neurosci Lett; 1995 Aug; 196(3):205-8. PubMed ID: 7501284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The adenosine receptor antagonist theophylline induces a monoamine-dependent increase of the anticataleptic effects of NMDA receptor antagonists.
    Hauber W; Münkle M
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Jul; 354(2):179-86. PubMed ID: 8857595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Behavioral effects of MK-801 on reserpine-treated mice.
    Dutra RC; Andreazza AP; Andreatini R; Tufik S; Vital MA
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Apr; 26(3):487-95. PubMed ID: 11999899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of vasopressin V1a receptor in ∆
    Egashira N; Koushi E; Myose T; Tanoue A; Mishima K; Tsuchihashi R; Kinjo J; Tanaka H; Morimoto S; Iwasaki K
    Psychopharmacology (Berl); 2017 Dec; 234(23-24):3475-3483. PubMed ID: 28905207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of NMDA receptor blockade and nitric oxide synthase inhibition on the acute and chronic actions of delta 9-tetrahydrocannabinol in mice.
    Thorat SN; Bhargava HN
    Brain Res; 1994 Dec; 667(1):77-82. PubMed ID: 7534610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The glycine transporter-1 inhibitor SSR103800 displays a selective and specific antipsychotic-like profile in normal and transgenic mice.
    Boulay D; Bergis O; Avenet P; Griebel G
    Neuropsychopharmacology; 2010 Jan; 35(2):416-27. PubMed ID: 19759529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of NMDA and AMPA/Kainate receptors in the consolidation of catalepsy sensitization.
    Riedinger K; Kulak A; Schmidt WJ; von Ameln-Mayerhofer A
    Behav Brain Res; 2011 Mar; 218(1):194-9. PubMed ID: 21130808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine-N-methyl-D-aspartate interactions in the modulation of locomotor activity and memory consolidation in mice.
    Mele A; Castellano C; Felici A; Cabib S; Caccia S; Oliverio A
    Eur J Pharmacol; 1996 Jul; 308(1):1-12. PubMed ID: 8836626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of D1 and D2 dopamine receptor antagonists and catecholamine depleting agents on the locomotor stimulation induced by dizocilpine in mice.
    Lapin IP; Rogawski MA
    Behav Brain Res; 1995 Oct; 70(2):145-51. PubMed ID: 8561905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Opposite effects of NMDA and AMPA receptor blockade on catalepsy induced by dopamine receptor antagonists.
    Papa SM; Engber TM; Boldry RC; Chase TN
    Eur J Pharmacol; 1993 Mar; 232(2-3):247-53. PubMed ID: 8385618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glutamatergic neurotransmission in the inferior colliculus influences intrastriatal haloperidol-induced catalepsy.
    Medeiros P; Viana MB; Barbosa-Silva RC; Tonelli LC; Melo-Thomas L
    Behav Brain Res; 2014 Jul; 268():8-13. PubMed ID: 24667361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Streptozotocin-induced diabetes differentially modifies haloperidol- and gamma-hydroxybutyric acid (GHB)-induced catalepsy.
    Sevak RJ; Koek W; France CP
    Eur J Pharmacol; 2005 Jul; 517(1-2):64-7. PubMed ID: 15975572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of N-methyl-D-aspartate (NMDA) receptors in noncompetitive NMDA receptor antagonist-induced hyperlocomotion in mice.
    Irifune M; Shimizu T; Nomoto M; Fukuda T
    Pharmacol Biochem Behav; 1995; 51(2-3):291-6. PubMed ID: 7667342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. State-dependent blockade of haloperidol-induced sensitization of catalepsy by MK-801.
    Schmidt WJ; Tzschentke TM; Kretschmer BD
    Eur J Neurosci; 1999 Sep; 11(9):3365-8. PubMed ID: 10510204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N-Methyl-D-aspartate receptor participation in Parkinson's disease, a neurodegenerative disorder.
    Verma A; Kulkarni SK
    Ann N Y Acad Sci; 1995 Sep; 765():327. PubMed ID: 7486633
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacological characteristics of zolpidem-induced catalepsy in the rat.
    Mierzejewski P; Kolaczkowski M; Nowak N; Korkosz A; Scinska A; Sienkiewicz-Jarosz H; Samochowiec J; Kostowski W; Bienkowski P
    Neurosci Lett; 2013 Nov; 556():99-103. PubMed ID: 24135337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Locomotor activation induced by MK-801 in the rat: postsynaptic interactions with dopamine receptors in the ventral striatum.
    Ouagazzal A; Nieoullon A; Amalric M
    Eur J Pharmacol; 1994 Jan; 251(2-3):229-36. PubMed ID: 8149978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The alpha 2-adrenoceptor antagonist idazoxan reverses catalepsy induced by haloperidol in rats independent of striatal dopamine release: role of serotonergic mechanisms.
    Invernizzi RW; Garavaglia C; Samanin R
    Neuropsychopharmacology; 2003 May; 28(5):872-9. PubMed ID: 12644843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The AMPA antagonists NBQX and GYKI 52466 do not counteract neuroleptic-induced catalepsy.
    Zadow B; Schmidt WJ
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Jan; 349(1):61-5. PubMed ID: 7908126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of antipsychotic treatments and D-serine supplementation on the electrophysiological activation of midbrain dopamine neurons induced by the noncompetitive NMDA antagonist MK 801.
    Bennett S; Gronier B
    Synapse; 2007 Aug; 61(8):679-88. PubMed ID: 17523181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.